Stock comparison

NTRAvsREGN

Natera IncvsRegeneron Pharmaceuticals Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

NTRA

Natera Inc

$201.14

-11.94%

Biotechnology$28.0BNASDAQ

REGN

Regeneron Pharmaceuticals Inc

$751.57

-0.14%

Biotechnology$79.2BNASDAQ

60-day price, rebased to 100

NTRA -13.11% · REGN +0.28%

Round-by-round

NTRA 2·REGN 3· 1tie

EdgeREGN

Valuation upside

-67.20% vs -21.10% to DCF fair value

EdgeNTRA

Balance-sheet strength

Altman Z 23.91 vs 7.40

Tie

Fundamental quality

Piotroski 5.00 vs 5.00 (of 9)

EdgeNTRA

Growth + margins

Rule-of-40 39.20 vs 27.20

EdgeREGN

60-day momentum

-13.11% vs +0.28% price return

EdgeREGN

Market-cap liquidity

$28.0B vs $79.2B

Verdict

Across6categories,REGNtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onNTRAorREGN

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.